National Healthcare, Corp. (NHC)
NYSE MKTHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$218.64-1.35%
Close 2026-09-04 · 1-day change
NYSE MKTHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
Warn: Management is running behind on a stated commitment.
National Healthcare grows by buying skilled nursing facilities. Revenue rose 16.1% in 2025 to $1.52 billion. They keep paying steady dividends of $0.64 per share. Management is disciplined with capital, using credit to fund growth.
Heavy borrowing to fund acquisitions could strain finances. Growth may slow if acquisitions do not add expected earnings. Dividend stability could be at risk if cash flow weakens.
The price is about 40% above our fair value near $154. Analysts expect 8% revenue growth, which is justified over 3-5 years. Our view sees value but the current price is rich versus fundamentals.
Breaks if: Credit usage exceeds $530 million without clear acquisition benefit
Focus on disciplined capital allocation including managing credit facilities and financing for acquisitions.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on growth through acquisitions in the skilled nursing sector. The current thesis state is intact, with recent financial results placing NHC in the upper half of its industry.
The market appears to have a neutral valuation outlook, with expectations that are somewhat aligned with current performance. There is a low level of fragility in the stock, suggesting that the market does not anticipate significant disruptions.
Fundamentals are likely to remain strong, given the recent revenue growth driven by acquisitions. However, there is a near-term risk of missing earnings expectations, as NHC has a history of consecutive misses.
The thesis hinges on management's ability to execute on M&A activities and maintain dividend payments. Additionally, external factors such as sector performance and economic indicators like job reports will play a crucial role in shaping future outcomes.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 3 material events in 2026 including July and May filings. NHC drew down $530M in credit facilities to fund acquisitions and increased revolving credit from $50M to $75M. These actions show delivering on enhancing capital allocation strategies to support growth.
Breaks if: Dividend per share falls below $0.64 in any quarter
Continue paying quarterly dividends to shareholders with modest increases over prior periods.
Maintained dividend payments consistently over 3 quarters from 2025-Q4 to 2026-Q2, with dividends per share rising modestly from $0.64 to $0.67. This shows delivering on the commitment to maintain shareholder distributions.
“Dividends declared per common share $0.67 for Q2 2026.”
“Dividends declared per common share $0.64 for Q1 2026.”
“Dividends declared per common share $0.64 for Q4 2025.”
Breaks if: Acquisition activity falls below $560 million in 2026-Q3
Continue acquiring skilled nursing and related healthcare facilities to grow operational footprint and revenue.
Stated as a priority in 3 disclosures including 2026-Q2 earnings and two 2026 press releases. Revenue grew 8.8% from $374.9M in 2025-Q2 to $408.0M in 2026-Q2, primarily driven by acquisitions. The $560M acquisition of 35 NHI facilities closed in Q3 2026, showing delivering progress on expanding M&A activity.
“Increase in net operating revenues for Q2 2026 primarily related to June 1, 2026 acquisition of five skilled nursing facilities.”
Overall, NHC's position looks stable for the next 1 to 3 years, but investors should monitor earnings closely. Not investment advice.